Teva Pharmaceutical Industries Quick Ratio 2010-2024 | TEVA

Teva Pharmaceutical Industries quick ratio for the quarter ending June 30, 2024 was 0.59.

  • Teva Pharmaceutical Industries average quick ratio for 2023 was 0.68, a 4.23% decline from 2022.
  • Teva Pharmaceutical Industries average quick ratio for 2022 was 0.71, a 1.43% decline from 2021.
  • Teva Pharmaceutical Industries average quick ratio for 2021 was 0.7, a 2.94% increase from 2020.

Quick ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated by subtracting inventory from current assets and dividing by current liabilities.

Teva Pharmaceutical Industries Quick Ratio 2010-2024 | TEVA

  • Teva Pharmaceutical Industries average quick ratio for 2023 was 0.68, a 4.23% decline from 2022.
  • Teva Pharmaceutical Industries average quick ratio for 2022 was 0.71, a 1.43% decline from 2021.
  • Teva Pharmaceutical Industries average quick ratio for 2021 was 0.7, a 2.94% increase from 2020.

Quick ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated by subtracting inventory from current assets and dividing by current liabilities.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$13.1B
BridgeBio Pharma (BBIO)$5B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.4B
Supernus Pharmaceuticals (SUPN)$1.8B
Taysha Gene Therapies (TSHA)$449M
Personalis (PSNL)$315M
Assembly Biosciences (ASMB)$117M
Acasti Pharma (ACST)$28M
Sol-Gel Technologies (SLGL)$20M
Evoke Pharma (EVOK)$4M
Teligent (TLGT)$0M